1. Home
  2. ANDE vs CLDX Comparison

ANDE vs CLDX Comparison

Compare ANDE & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANDE
  • CLDX
  • Stock Information
  • Founded
  • ANDE 1947
  • CLDX N/A
  • Country
  • ANDE United States
  • CLDX United States
  • Employees
  • ANDE N/A
  • CLDX N/A
  • Industry
  • ANDE Farming/Seeds/Milling
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • ANDE Industrials
  • CLDX Health Care
  • Exchange
  • ANDE Nasdaq
  • CLDX Nasdaq
  • Market Cap
  • ANDE 1.3B
  • CLDX 1.3B
  • IPO Year
  • ANDE N/A
  • CLDX 2008
  • Fundamental
  • Price
  • ANDE $38.45
  • CLDX $24.90
  • Analyst Decision
  • ANDE Buy
  • CLDX Strong Buy
  • Analyst Count
  • ANDE 3
  • CLDX 8
  • Target Price
  • ANDE $51.67
  • CLDX $51.86
  • AVG Volume (30 Days)
  • ANDE 347.1K
  • CLDX 983.5K
  • Earning Date
  • ANDE 08-04-2025
  • CLDX 08-07-2025
  • Dividend Yield
  • ANDE 2.01%
  • CLDX N/A
  • EPS Growth
  • ANDE N/A
  • CLDX N/A
  • EPS
  • ANDE 2.35
  • CLDX N/A
  • Revenue
  • ANDE $11,539,093,000.00
  • CLDX $5,790,000.00
  • Revenue This Year
  • ANDE $3.48
  • CLDX N/A
  • Revenue Next Year
  • ANDE $4.79
  • CLDX N/A
  • P/E Ratio
  • ANDE $16.51
  • CLDX N/A
  • Revenue Growth
  • ANDE N/A
  • CLDX N/A
  • 52 Week Low
  • ANDE $31.03
  • CLDX $14.40
  • 52 Week High
  • ANDE $51.58
  • CLDX $47.00
  • Technical
  • Relative Strength Index (RSI)
  • ANDE 56.87
  • CLDX 61.10
  • Support Level
  • ANDE $31.84
  • CLDX $19.72
  • Resistance Level
  • ANDE $40.66
  • CLDX $25.79
  • Average True Range (ATR)
  • ANDE 1.54
  • CLDX 1.38
  • MACD
  • ANDE 0.41
  • CLDX 0.22
  • Stochastic Oscillator
  • ANDE 74.94
  • CLDX 79.08

About ANDE Andersons Inc. (The)

Andersons Inc is a diversified company with its main focus in the agriculture sector. Its operations are segmented into Trade, Renewables, and Nutrient & Industrial. The Trade segment, which generates the majority of the revenue, is engaged in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. Geographically, the company generates the majority of its revenue from the United States and the rest from Canada, Mexico, Egypt, Switzerland, and other markets.

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Share on Social Networks: